RxDoctor Payments Data
★ My doctorsLook up a doctor →

Paul Markovitz

Psychiatry · Fresno, CANPI 1083739767

Payments from drug & device makers

$61,930in general payments, 2019–2025

Across 220 payments — averaging $281.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$60K
  • Takeda Pharmaceuticals U.S.A., Inc.$462
  • AbbVie$383
  • Lundbeck LLC$315
  • Sunovion Pharmaceuticals Inc.$114
  • Jazz Pharmaceuticals Inc.$104
  • plus $194 from 3 others

What the payments were for

  • Speaking & faculty fees$50,70082%
  • Travel & lodging$7,86313%
  • Food & beverage$3,3665%
  • Education$10%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Neurocrine Biosciences, Inc.101$60,359
Takeda Pharmaceuticals U.S.A., Inc.56$462
AbbVie(2 entities)24$383
Lundbeck LLC19$315
Sunovion Pharmaceuticals Inc.2$114
Jazz Pharmaceuticals Inc.6$104
Eisai Inc.6$96
Avanir Pharmaceuticals, Inc.4$69
Vanda Pharmaceuticals Inc.2$29

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$61,930 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Other psychiatry in Fresno

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →